Home
/
Genprex, Inc.
/
Financials
/
Quarterly
Genprex, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Genprex, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 30, 2022
$0
Nov 14, 2022
Q2
2022
Jun 30, 2022
$0
Aug 12, 2022
Q1
2022
Mar 31, 2022
$0
May 13, 2022
Q3
2022
Sep 30, 2021
$0
Nov 14, 2022
Q2
2022
Jun 30, 2021
$0
Aug 12, 2022
Q1
2022
Mar 31, 2021
$0
May 13, 2022
Q3
2021
Sep 30, 2020
$0
Nov 15, 2021
Q2
2021
Jun 30, 2020
$0
Aug 13, 2021
Q1
2019
Mar 31, 2019
$0
May 20, 2019
Q3
2018
Sep 30, 2018
$0
Nov 14, 2018
Q2
2018
Jun 30, 2018
$0
Aug 14, 2018
Q1
2019
Mar 31, 2018
$0
May 20, 2019
Q3
2018
Sep 30, 2017
$0
Nov 14, 2018
Q2
2018
Jun 30, 2017
$0
Aug 14, 2018
Q1
2018
Mar 31, 2017
$0
May 15, 2018
Q3
2017
Sep 30, 2016
$0
Dec 5, 2017
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.80M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($4.67M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($4.67M)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($3.96M)
May 12, 2025
Q3
2025
Mar 31, 2025
($3.96M)
Nov 14, 2025
Q2
2025
Mar 31, 2025
($3.96M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($4.32M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($6.50M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($6.50M)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($5.97M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($5.97M)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($5.97M)
May 12, 2025
Q3
2024
Sep 30, 2023
($7.75M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($7.98M)
Aug 9, 2024
Q3
2024
Jun 30, 2023
($7.98M)
Nov 13, 2024
Q1
2024
Mar 31, 2023
($9.20M)
May 15, 2024
Q2
2024
Mar 31, 2023
($9.20M)
Aug 9, 2024
Q3
2024
Mar 31, 2023
($9.20M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
($6.14M)
Nov 14, 2023
Q3
2023
Jun 30, 2022
($5.76M)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.35M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($4.68M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.97M)
May 12, 2025
Q3
2025
Sep 30, 2024
($4.32M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($6.52M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($6.00M)
May 12, 2025
Q3
2024
Sep 30, 2023
($7.79M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($8.04M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($9.26M)
May 15, 2024
Q3
2023
Sep 30, 2022
($6.17M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($5.77M)
Aug 21, 2023
Q1
2023
Mar 31, 2022
($5.31M)
May 22, 2023
Q3
2022
Sep 30, 2021
($3.44M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($3.99M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($6.49M)
May 13, 2022
Q3
2021
Sep 30, 2020
($2.78M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($4.38M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($5.58M)
May 17, 2021
Q3
2020
Sep 30, 2019
($2.38M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($3.70M)
Aug 11, 2020